X-106928690-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020384.4(CLDN2):āc.462C>Gā(p.Asp154Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000182 in 1,097,687 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020384.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLDN2 | NM_020384.4 | c.462C>G | p.Asp154Glu | missense_variant | 2/2 | ENST00000336803.2 | NP_065117.1 | |
CLDN2 | NM_001171092.1 | c.462C>G | p.Asp154Glu | missense_variant | 2/2 | NP_001164563.1 | ||
CLDN2 | NM_001171095.2 | c.462C>G | p.Asp154Glu | missense_variant | 2/2 | NP_001164566.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLDN2 | ENST00000336803.2 | c.462C>G | p.Asp154Glu | missense_variant | 2/2 | 2 | NM_020384.4 | ENSP00000336571 | P1 | |
CLDN2 | ENST00000540876.1 | c.462C>G | p.Asp154Glu | missense_variant | 2/2 | 1 | ENSP00000443230 | P1 | ||
CLDN2 | ENST00000541806.6 | c.462C>G | p.Asp154Glu | missense_variant | 2/2 | 1 | ENSP00000441283 | P1 | ||
MORC4 | ENST00000604604.1 | c.111+64540G>C | intron_variant | 2 | ENSP00000474750 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1097687Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 363051
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 30, 2024 | The c.462C>G (p.D154E) alteration is located in exon 2 (coding exon 1) of the CLDN2 gene. This alteration results from a C to G substitution at nucleotide position 462, causing the aspartic acid (D) at amino acid position 154 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at